c
Edmonton
airing now
101.7 FM
|
88.1HD2
airing now
8.85 c
Edmonton
airing now
101.7 FM
|
88.1HD2

Final stage testing for Novavax COVID-19 vaccine candidate is getting underway in the US today

BY , Dec 28, 2020 6:19 PM - REPORT AN ERROR

A huge study of the Novavax COVID-19 vaccine candidate is getting underway in the US today.

This is the fifth drug to reach final-stage testing south of the border.

About 30,000 volunteers are needed to prove if this vaccine, which is a different kind than its Pfizer and Moderna competitors, really works and is safe.

"If you want to have enough vaccine to vaccinate all the people in the U.S. who you'd like to vaccinate, up to 85% or more of the population, you're going to need more than two companies,'' Dr. Anthony Fauci, the top U.S. infectious disease expert, told The Associated Press.

The Novavax candidate uses lab-grown harmless copies of the spike protein that coats the coronavirus to train the body to recognize if the real virus comes along.

Latest News

Share on

Sign up for the newsletter
We'll deliver best of entertainment right into your inbox
We love to hear from our listeners, so feel free to send us message
whatsUp icon
Message us on whatsapp